EHMT2 and hepatocellular carcinoma: Nanodiamond-mediated delivery of the G9a inhibitor UNC0646 maintained the biological functionality of UNC0646, with improved efficacy in reducing H3K9 methylation as well as enhancing the suppression of invasion in HCC cells,219 laying the foundation for future administration of small molecule histone methylation-regulating drugs.